186 related articles for article (PubMed ID: 23289794)
1. Phosphorothioate-modified CpG oligodeoxynucleotides mimic autoantigens and reveal a potential role for Toll-like receptor 9 in receptor revision.
Doster A; Ziegler S; Foermer S; Rieker RJ; Heeg K; Bekeredjian-Ding I
Immunology; 2013 Jun; 139(2):166-78. PubMed ID: 23289794
[TBL] [Abstract][Full Text] [Related]
2. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
Vollmer J; Weeratna RD; Jurk M; Samulowitz U; McCluskie MJ; Payette P; Davis HL; Schetter C; Krieg AM
Immunology; 2004 Oct; 113(2):212-23. PubMed ID: 15379982
[TBL] [Abstract][Full Text] [Related]
3. CpG-oligodeoxynucleotide inhibits Smad-dependent bone morphogenetic protein signaling: effects on myeloma cell apoptosis and in vitro osteoblastogenesis.
Nørgaard NN; Holien T; Jönsson S; Hella H; Espevik T; Sundan A; Standal T
J Immunol; 2010 Sep; 185(6):3131-9. PubMed ID: 20702733
[TBL] [Abstract][Full Text] [Related]
4. Involvement of DNA-PKcs in the type I IFN response to CpG-ODNs in conventional dendritic cells in TLR9-dependent or -independent manners.
Ma C; Spies NP; Gong T; Jones CX; Chu WM
PLoS One; 2015; 10(3):e0121371. PubMed ID: 25812014
[TBL] [Abstract][Full Text] [Related]
5. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.
Hornung V; Rothenfusser S; Britsch S; Krug A; Jahrsdörfer B; Giese T; Endres S; Hartmann G
J Immunol; 2002 May; 168(9):4531-7. PubMed ID: 11970999
[TBL] [Abstract][Full Text] [Related]
6. Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses.
Nündel K; Green NM; Shaffer AL; Moody KL; Busto P; Eilat D; Miyake K; Oropallo MA; Cancro MP; Marshak-Rothstein A
J Immunol; 2015 Mar; 194(6):2504-12. PubMed ID: 25681333
[TBL] [Abstract][Full Text] [Related]
7. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
Abu-Rish EY; Amrani Y; Browning MJ
Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
[TBL] [Abstract][Full Text] [Related]
9. CpG-oligodeoxynucleotides stimulate immunoglobulin A secretion in intestinal mucosal B cells.
Blaas SH; Stieber-Gunckel M; Falk W; Obermeier F; Rogler G
Clin Exp Immunol; 2009 Mar; 155(3):534-40. PubMed ID: 19220839
[TBL] [Abstract][Full Text] [Related]
10. B-cell activating factor (BAFF) promotes CpG ODN-induced B cell activation and proliferation.
Buchanan RM; Popowych Y; Arsic N; Townsend HG; Mutwiri GK; Potter AA; Babiuk LA; Griebel PJ; Wilson HL
Cell Immunol; 2011; 271(1):16-28. PubMed ID: 21724179
[TBL] [Abstract][Full Text] [Related]
11. Engagement of the B cell receptor for antigen differentially affects B cell responses to Toll-like receptor-7 agonists and antagonists in BXSB mice.
Layer T; Steele A; Goeken JA; Fleenor S; Lenert P
Clin Exp Immunol; 2011 Mar; 163(3):392-403. PubMed ID: 21235537
[TBL] [Abstract][Full Text] [Related]
12. Phosphorothioate modification of the TLR9 ligand CpG ODN inhibits poly(I:C)-induced apoptosis of hepatocellular carcinoma by entry blockade.
Zhang Y; Lin A; Sui Q; Zhang C; Tian Z; Zhang J
Cancer Lett; 2014 Dec; 355(1):76-84. PubMed ID: 25224571
[TBL] [Abstract][Full Text] [Related]
13. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
[TBL] [Abstract][Full Text] [Related]
14. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.
He B; Qiao X; Cerutti A
J Immunol; 2004 Oct; 173(7):4479-91. PubMed ID: 15383579
[TBL] [Abstract][Full Text] [Related]
15. Nuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human Toll-like receptor 9 agonists.
Meng W; Yamazaki T; Nishida Y; Hanagata N
BMC Biotechnol; 2011 Sep; 11():88. PubMed ID: 21943407
[TBL] [Abstract][Full Text] [Related]
16. Optimal oligonucleotide sequences for TLR9 inhibitory activity in human cells: lack of correlation with TLR9 binding.
Ashman RF; Goeken JA; Latz E; Lenert P
Int Immunol; 2011 Mar; 23(3):203-14. PubMed ID: 21393636
[TBL] [Abstract][Full Text] [Related]
17. B cell receptor revision diminishes the autoreactive B cell response after antigen activation in mice.
Wang YH; Diamond B
J Clin Invest; 2008 Aug; 118(8):2896-907. PubMed ID: 18636122
[TBL] [Abstract][Full Text] [Related]
18. B-cell receptor for antigen modulates B-cell responses to complex TLR9 agonists and antagonists: implications for systemic lupus erythematosus.
Goeken JA; Layer T; Fleenor S; Laccheo M; Lenert P
Lupus; 2010 Oct; 19(11):1290-301. PubMed ID: 20605877
[TBL] [Abstract][Full Text] [Related]
19. Differential cytokine production and bystander activation of autoreactive B cells in response to CpG-A and CpG-B oligonucleotides.
Avalos AM; Latz E; Mousseau B; Christensen SR; Shlomchik MJ; Lund F; Marshak-Rothstein A
J Immunol; 2009 Nov; 183(10):6262-8. PubMed ID: 19864612
[TBL] [Abstract][Full Text] [Related]
20. Primary development and participation in a foreign antigen-driven immune response of a chromatin-reactive B cell clonotype are not influenced by TLR9 or other MyD88-dependent TLRs.
Coffey F; Liu X; Manser T
J Immunol; 2007 Nov; 179(10):6663-72. PubMed ID: 17982056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]